Given the success of
Volume I of this Research Topic, and how rapid the subject area is evolving, we are pleased to announce the launch of The Upcoming Complications of COVID-19 on Recovered Patients: Molecular Mechanisms and Therapeutic Opportunities - Volume II
BackgroundCovid-19 is currently a debilitating threat to human life. While hopes for a vaccine to control the spread of the disease in the world keep growing, unfortunately recent findings indicate that there are signs of other unpredicted complications in patients recovered from Covid-19. In fact, COVID-19-recovered patients seem to be prone to develop various diseases, infections, disorders, and complications during their lifespan. These include the development of various chronic diseases, impact on longevity, as well as autoimmune diseases and susceptibility to infections.
GoalThis means that the main concern, when the spread of Covid-19 is finally managed, is the type and severity of clinical complications in treated individuals. In this context, identifying the implicated molecular pathways and mechanisms related to the pathogenesis of Covid-19 in the development/reactivation of underlying diseases/disorders can lead to the development of therapeutic opportunities to predict and prevent the occurrence of symptoms, and metabolic, mental disorders, and autoimmune disease in Covid-19 recovered patients in the future.
ScopeWe call for papers that critically address the mechanisms and molecular basis in recovered patients prone to developing other diseases during their lifetime, focusing particularly on possible therapeutic options relevant to one of the following subjects:
1. COVID-19 in patients with cancer
2. COVID-19 and susceptibility to bacterial/viral infections (e.g. tuberculosis, HIV,…)
3. COVID-19 and susceptibility to autoimmune diseases
4. COVID-19 and susceptibility to metabolic diseases (for example, diabetes)
5. COVID-19 and susceptibility to other diseases (for example, kidney failure, heart failure, respiratory)
6. COVID-19 and effects on longevity and life expectancy
7. COVID-19 and its mental/behavioral effects